Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV

Journal of Microbiology, Immunology and Infection

Volumn 53, Issue 3, 2020, Pages 365-367

  Lee, Ping Ing ^a   Hsueh, Po Ren ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARBIDOL; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NUCLEOSIDE ANALOG; REMDESIVIR; SIALIDASE INHIBITOR; TENOFOVIR DISOPROXIL; UMIFENOVIR; ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; CHINESE MEDICINE; CONTACT EXAMINATION; CORONAVIRUS DISEASE 2019; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PANDEMIC; PNEUMONIA; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; TAIWAN; UPPER RESPIRATORY TRACT INFECTION; VIRUS CARRIER; VIRUS STRAIN; VIRUS TRANSMISSION; ANIMAL; BETACORONAVIRUS; COMMUNICABLE DISEASE; CORONAVIRINAE; CORONAVIRUS INFECTION; HOST RANGE; HUMAN; PATHOGENICITY; SEVERE ACUTE RESPIRATORY SYNDROME; VETERINARY MEDICINE; VIROLOGY; VIRUS PNEUMONIA; ZOONOSIS;

ANIMALS; ANTIVIRAL AGENTS; BETACORONAVIRUS; COMMUNICABLE DISEASES, EMERGING; CORONAVIRUS; CORONAVIRUS INFECTIONS; HOST SPECIFICITY; HUMANS; PANDEMICS; PNEUMONIA, VIRAL; SEVERE ACUTE RESPIRATORY SYNDROME; ZOONOSES;

EID: 85078958617     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2020.02.001     Document Type: Article

References (12)

1. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020 Jan 24, 10.1056/NEJMoa2001017 [Epub ahead of print].
2. Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020 Jan 29, 10.1056/NEJMoa2001316.
3. Lee, K.H., Yoo, S.G., Cho, Y., Kwon, D.E., La, Y., Han, S.H., et al. Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients. J Microbiol Immunol Infect, 2019 Jun 19, 10.1016/j.jmii.2019.05.007 [Epub ahead of print].
4. Alfaraj, S.H., Al-Tawfiq, J.A., Memish, Z.A., Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: report of two cases & review of the literature. J Microbiol Immunol Infect 52 (2019), 501–503.
5. Munster, V.J., Koopmans, M., van Doremalen, N., van Riel, D., de Wit, E., A novel coronavirus emerging in China — key questions for impact assessment. N Engl J Med, 2020 Jan 24, 10.1056/NEJMp2000929 [Epub ahead of print].
6. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020 Jan 24, 10.1016/S0140-6736(20)30183-5 [Epub ahead of print].
7. Perlman, S., Another decade, another coronavirus. N Engl J Med, 2020 Jan 24, 10.1056/NEJMe2001126 [Epub ahead of print].
8. Enserink, M., SARS: chronology of the epidemic. Science 339 (2013), 1266–1271.
9. Raj, V.S., Mou, H., Smits, S.L., Dekkers, D.H., Müller, M.A., Dijkman, R., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:7440 (2013), 251–254.
10. Zhong, N., Zeng, G., What we have learnt from SARS epidemics in China. Br Med J 19:333 (2006), 389–391.
11. Lu, H.Z., Drug treatment options for the 2019-new coronavirus (2019- nCoV). BioSci Trends, 2020, 10.5582/bst.2020.01020 Advance Publication.
12. Holshue, M.L., DeBolt, C., Lindquist, S., Lofy, K.H., Wiesman, J., Bruce, H., et al. First case of 2019 novel coronavirus in the United States. N Engl J Med, 2020 Jan 31, 10.1056/NEJMoa2001191.